The health data analytics provider counts Johnson & Johnson, McKesson, Amgen, Sanofi, UCB Pharma and Blue Cross Blue Shield of New Jersey as earlier investors.

Aetion, a US-based healthcare data software provider backed by corporates Johnson & Johnson, McKesson, Amgen, Sanofi, UCB Pharma and Blue Cross Blue Shield of New Jersey, completed a $110m series C round on Tuesday

Private equity firm Warburg Pincus led the round, which included investment firm Foresite Capital and venture capital firms B Capital Group, New Enterprise Associates (NEA) and Flare Capital Partners. The company said it has now raised $212m altogether.

Founded in 2013, Aetion has built an analytics…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn